from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3409c/choD

LFCtreatmentdescriptionclass of inhibitor

-1.407

Amikacinug/mL Amikacintranslation

-0.908

Cap5-10ug/mL Capreomycintranslation

-1.218

Rox10-50 ug/mL Roxithromycintranslation

0.437

SM2-5 ug/mL Streptomycintranslation

1.994

Tet5-10 ug/mL Tetracyclinetranslation

1.111

Rif0.2-5ug/mL Rifampicintranscription

0.661

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.441

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.731

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.312

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.384

Clofazimine10-13 ug/mL Clofaziminerespiration

0.534

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.642

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.186

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.216

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.153

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.377

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.856

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.195

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.559

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.967

KCN5-20 ug/mL Potassium cyaniderespiration

1.331

NaN30.2-2 mM Sodium aziderespiration

0.147

Nigericin50 uM Nigericinrespiration

0.522

TRC10-150 ug/mL Triclosanrespiration

-0.983

TRZ10-25 ug/mL Thioridazinerespiration

-1.719

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.370

menadione6-10 ug/mL Menadionerespiration

0.099

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.283

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.023

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.169

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.409

NRP_1Non-replicating persistence stage 1dosRassociated

-0.123

Amp0.2mg/mL AmpicillincellWall

-0.001

Cephalexin20-100 ug/mL CephalexincellWall

-0.459

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.417

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.106

EMB10-20 ug/mL EthambutolcellWall

-0.097

Eta12-40 ug/mL EthionamidecellWall

-0.135

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.160

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.327

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.090

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.132

BZA0.12 mg/mL BenzamidearomaticAmides

-0.401

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.129

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.341

H2O24 mM hydrogen peroxideDNAdamaging

-0.214

Levo10 ug/mL LevofloxacinDNAdamaging

-0.156

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.444

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.163

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.634

UVUV-irradiationDNAdamaging

-0.133

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.257

Antimycin12.5-50 ug/mL Antimycin A?

-0.453

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.156

PA_110-50 ug/mL Antitubercular compound PA-1?

0.087

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.459

PA8240.2-2 ug/mL PA-824?

1.183

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.729

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.345

Verapamil50 uM Verapamil?

-1.130

mercaptoethanol2 mM 2-Mercaptoethanol?

0.243

methoxatin10-20 ug/mL Methoxatin?